Atara Biotherapeutics
ATRA
ATRA
89 hedge funds and large institutions have $34.1M invested in Atara Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
54% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 35
74% less capital invested
Capital invested by funds: $131M → $34.1M (-$96.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
89
Holding in Top 10
–
Calls
$23K
Puts
$27K
Top Buyers
| 1 | +$5.16M | |
| 2 | +$1.86M | |
| 3 | +$1.45M | |
| 4 |
Millennium Management
New York
|
+$1.33M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.07M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$12.4M | |
| 3 | -$9.31M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$3.32M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.44M |